Duchenne Muscular Dystrophy Therapeutics Market Surges Toward $6.6B by 2033 as Gene and RNA Therapies Redefine Treatment Paradigm | by DataM Intelligence
The Global Duchenne Muscular Dystrophy (DMD) Therapeutics MarketSize was valued at US $2.19 billion in 2024, it is projected to surge to US $6.64 billion by 2033, expanding at a CAGR of 13.2% during 2025-2033. This remarkable trajectory reflects a paradigm shift in muscular dystrophy management-from symptomatic relief to advanced genetic and molecular solutions capable […]